Molecular Devices, MIMETAS Sign Co-marketing Agreement

News   Feb 06, 2017 | Original story from MIMETAS

 
Molecular Devices, MIMETAS Sign Co-marketing Agreement
 
 
 

RELATED ARTICLES

Freedom of Information Request Reveals Benefits of Blocked MS Drug

News

A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

READ MORE

Blood-vessel-on-a-Chip Models Vascular Barrier Function

News

A newly developed human blood-vessel-on-a-chip models the vascular barrier and reveals a new cell migration-based mechanism for fibrotic diseases.

READ MORE

Mercury Is Altering Gene Expression

News

New research claims that mercury found in highly contaminated fish can cause irreversible neurological disorders in people who have consumed them.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery Microfluidics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE